(Q35998759)

11 August 2017

1 reference

title

Osteoblasts in prostate cancer metastasis to bone (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

Christopher J Logothetis

series ordinal

1

1 reference

PubMed ID

15630412

11 August 2017

Sue-Hwa Lin

series ordinal

2

1 reference

PubMed ID

15630412

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 August 2017

Nature Reviews Cancer

1 reference

11 August 2017

5

1 reference

11 August 2017

21-28

1 reference

11 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1528

11 August 2017

0 references

cites work

Spread of prostatic cancer to bone

1 reference

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

21 January 2018

1 reference

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

21 January 2018

1 reference

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

21 January 2018

1 reference

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

21 January 2018

1 reference

Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate

21 January 2018

1 reference

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial

21 January 2018

1 reference

Growth regulatory factors and bone

21 January 2018

1 reference

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

21 January 2018

1 reference

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

21 January 2018

1 reference

Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.

21 January 2018

1 reference

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway

21 January 2018

1 reference

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

21 January 2018

1 reference

Functional interaction of beta-catenin with the transcription factor LEF-1

21 January 2018

1 reference

Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF

21 January 2018

1 reference

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies

21 January 2018

1 reference

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

The IGF-I receptor in cell growth, transformation and apoptosis.

21 January 2018

1 reference

Insulin-like growth factors and their binding proteins: biological actions

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells

21 January 2018

1 reference

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

21 January 2018

1 reference

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

21 January 2018

1 reference

Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts

21 January 2018

1 reference

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts

21 January 2018

1 reference

Osteoclast differentiation and activation

21 January 2018

1 reference

Dissociation between bone resorption and bone formation in osteopenic transgenic mice

21 January 2018

1 reference

LuCaP 35: A new model of prostate cancer progression to androgen independence

21 January 2018

1 reference

A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49

21 January 2018

1 reference

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

21 January 2018

1 reference

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

21 January 2018

1 reference

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

21 January 2018

1 reference

Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan

31 March 2020

1 reference

The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae

31 March 2020

1 reference

The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2

31 March 2020

1 reference

Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin

31 March 2020

1 reference

Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells

31 March 2020

1 reference

Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy

31 March 2020

1 reference

Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States)

31 March 2020

1 reference

Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule

31 March 2020

1 reference

In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma

31 March 2020

1 reference

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

31 March 2020

1 reference

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

31 March 2020

1 reference

Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen

31 March 2020

1 reference

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

31 March 2020

1 reference

Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow

31 March 2020

1 reference

Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow

31 March 2020

1 reference

Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow

31 March 2020

1 reference

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

31 March 2020

1 reference

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

31 March 2020

1 reference

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells

31 March 2020

1 reference

Isolation of a human prostate carcinoma cell line (DU 145)

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1528

1 reference

11 August 2017

1 reference

PubMed ID

15630412